EZH2 and hepatocellular carcinoma: Using chromatin immunoprecipitation microarray (ChIP-Chip) analysis, Cheng and colleagues discovered a panel of Wnt pathway inhibitors whose promoters were concordantly occupied by enhancer of zeste homolog 2 (EZH2) and H3K27me3 in HCC cells [14].